Tag Archives: Neon Therapeutics

Why Did JonesTrading Downgrade Neon Therapeutics’ Stock?

In a report released today, Soumit Roy from JonesTrading downgraded Neon Therapeutics (NTGN – Research Report) to Hold. The company’s shares closed last Monday at $1.79, close to its 52-week low of $0.88. According to TipRanks.com, Roy is a 5-star

Mizuho Securities Sticks to Their Buy Rating for Neon Therapeutics (NTGN)

In a report released yesterday, Salim Syed from Mizuho Securities maintained a Buy rating on Neon Therapeutics (NTGN – Research Report), with a price target of $21.00. The company’s shares closed last Monday at $1.43, close to its 52-week low

Mizuho Securities Sticks to Its Buy Rating for Neon Therapeutics (NTGN)

Mizuho Securities analyst Salim Syed maintained a Buy rating on Neon Therapeutics (NTGN – Research Report) today and set a price target of $21.00. The company’s shares closed last Monday at $1.97, close to its 52-week low of $1.61. According

H.C. Wainwright Remains a Buy on Neon Therapeutics (NTGN)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Neon Therapeutics (NTGN – Research Report), with a price target of $12.00. The company’s shares closed last Monday at $2.00, close to its 52-week low

JonesTrading Reaffirms Their Buy Rating on Neon Therapeutics (NTGN)

In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Neon Therapeutics (NTGN – Research Report), with a price target of $30.00. The company’s shares closed last Monday at $2.00, close to its 52-week low of

Neon Therapeutics (NTGN) Receives a Buy from Mizuho Securities

Mizuho Securities analyst Salim Syed maintained a Buy rating on Neon Therapeutics (NTGN – Research Report) today and set a price target of $21.00. The company’s shares closed last Monday at $1.99, close to its 52-week low of $1.61. According